Farnesyl protein transferase inhibitors as antitumor agents

Disclosed are novel tricyclic compounds represented by the formula (1.0): and a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising compounds of formula 1.0. Also disclose...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhu, Hugh Y, Njoroge, F. George, Cooper, Alan B, Guzi, Timothy J, Rane, Dinanath F, Minor, Keith P, Doll, Ronald J, Girijavallabhan, Viyyoor M, Santhanam, Bama, Pinto, Patrick A, Vibulbhan, Bancha, Keertikar, Kartik M, Alvarez, Carmen S, Baldwin, John J, Li, Ge, Huang, Chia-Yu, James, Ray A, Wang, James J-S, Desai, Jagdish A
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed are novel tricyclic compounds represented by the formula (1.0): and a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising compounds of formula 1.0. Also disclosed are methods of treating cancer using the compounds of formula 1.0.